Well-Differentiated Papillary Mesothelioma of the Peritoneum Is Genetically Distinct from Malignant Mesothelioma

Raunak Shrestha1,2,3, Noushin Nabavi1,4, Stanislav Volik1

  • 1Vancouver Prostate Centre, Vancouver, BC V6H 3ZH, Canada.

Cancers
|June 18, 2020
PubMed

Insights

Well-differentiated papillary mesothelioma (WDPM) is a distinct neoplasm, not a reactive process or precursor to malignant mesothelioma. Genetic analysis reveals unique mutations in WDPM, differentiating it from malignant mesothelioma.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • Well-differentiated papillary mesothelioma (WDPM) is an uncommon mesothelial proliferation often found incidentally in the peritoneum.
  • Its classification as a neoplasm or reactive process, and its relationship to malignant mesothelioma, remain debated.

Purpose of the Study:

  • To genetically characterize WDPM and determine its relationship to malignant mesothelioma.
  • To resolve the controversy regarding the neoplastic or reactive nature of WDPM.

Main Methods:

  • Whole exome sequencing was performed on five peritoneal WDPM samples.
  • Genetic alterations in WDPM were compared to those typically found in malignant mesotheliomas.

Main Results:

  • WDPM samples exhibited distinct mutations in genes including EHD1, ATM, FBXO10, SH2D2A, CDH5, MAGED1, and TP73.
  • A unique mutational signature (C > A transversions) was observed in WDPM, absent in malignant mesotheliomas.
  • WDPM lacked common malignant mesothelioma mutations in genes like BAP1, SETD2, and NF2.

Conclusions:

  • WDPM represents a neoplastic entity genetically distinct from malignant mesothelioma.
  • Based on genetic profiles, WDPM does not appear to be a precursor to malignant mesothelioma.